121 related articles for article (PubMed ID: 25934286)
1. Deconstructing the role of the ECM microenvironment on drug efficacy targeting MAPK signaling in a pre-clinical platform for cutaneous melanoma.
Blehm BH; Jiang N; Kotobuki Y; Tanner K
Biomaterials; 2015 Jul; 56():129-39. PubMed ID: 25934286
[TBL] [Abstract][Full Text] [Related]
2. Patterning microscale extracellular matrices to study endothelial and cancer cell interactions in vitro.
Dickinson LE; Lütgebaucks C; Lewis DM; Gerecht S
Lab Chip; 2012 Nov; 12(21):4244-8. PubMed ID: 22992844
[TBL] [Abstract][Full Text] [Related]
3. Tissue-engineered 3D melanoma model with blood and lymphatic capillaries for drug development.
Bourland J; Fradette J; Auger FA
Sci Rep; 2018 Sep; 8(1):13191. PubMed ID: 30181613
[TBL] [Abstract][Full Text] [Related]
4. Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research?
Aleman JD; Young CD; Karam SD; Wang XJ
Mol Carcinog; 2023 Jan; 62(1):5-23. PubMed ID: 35596706
[TBL] [Abstract][Full Text] [Related]
5. Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance.
Popovic A; Tartare-Deckert S
Front Oncol; 2022; 12():924553. PubMed ID: 36119516
[TBL] [Abstract][Full Text] [Related]
6. In vivo tissue has non-linear rheological behavior distinct from 3D biomimetic hydrogels, as determined by AMOTIV microscopy.
Blehm BH; Devine A; Staunton JR; Tanner K
Biomaterials; 2016 Mar; 83():66-78. PubMed ID: 26773661
[TBL] [Abstract][Full Text] [Related]
7. Independent Control of Topography for 3D Patterning of the ECM Microenvironment.
Kim J; Staunton JR; Tanner K
Adv Mater; 2016 Jan; 28(1):132-7. PubMed ID: 26551393
[TBL] [Abstract][Full Text] [Related]
8. Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models.
Kim J; Tanner K
Front Oncol; 2015; 5():170. PubMed ID: 26284194
[TBL] [Abstract][Full Text] [Related]
9. 3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.
DelNero P; Lane M; Verbridge SS; Kwee B; Kermani P; Hempstead B; Stroock A; Fischbach C
Biomaterials; 2015 Jul; 55():110-8. PubMed ID: 25934456
[TBL] [Abstract][Full Text] [Related]
10. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing.
Salton M; Kasprzak WK; Voss T; Shapiro BA; Poulikakos PI; Misteli T
Nat Commun; 2015 May; 6():7103. PubMed ID: 25971842
[TBL] [Abstract][Full Text] [Related]
12. Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma.
Cheng H; Terai M; Kageyama K; Ozaki S; McCue PA; Sato T; Aplin AE
Cancer Res; 2015 Jul; 75(13):2737-48. PubMed ID: 25952648
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
Yin T; Wang L; Yin L; Zhou J; Huo M
Biomaterials; 2015 Aug; 61():10-25. PubMed ID: 25996409
[TBL] [Abstract][Full Text] [Related]
14. Circulating biomarkers in malignant melanoma.
Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
[TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival.
Afasizheva A; Devine A; Tillman H; Fung KL; Vieira WD; Blehm BH; Kotobuki Y; Busby B; Chen EI; Tanner K
BMC Cancer; 2016 Mar; 16():186. PubMed ID: 26944546
[TBL] [Abstract][Full Text] [Related]
16. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix as target for antitumor therapy.
Harisi R; Jeney A
Onco Targets Ther; 2015; 8():1387-98. PubMed ID: 26089687
[TBL] [Abstract][Full Text] [Related]
18. MCL-1, BCL-XL and MITF Are Diversely Employed in Adaptive Response of Melanoma Cells to Changes in Microenvironment.
Hartman ML; Talar B; Gajos-Michniewicz A; Czyz M
PLoS One; 2015; 10(6):e0128796. PubMed ID: 26035829
[TBL] [Abstract][Full Text] [Related]
19. An upconversion luminescence nanoprobe for the ultrasensitive detection of hyaluronidase.
Wang Z; Li X; Song Y; Li L; Shi W; Ma H
Anal Chem; 2015 Jun; 87(11):5816-23. PubMed ID: 25947627
[TBL] [Abstract][Full Text] [Related]
20. YAP localization mediates mechanical adaptation of human cancer cells during extravasation
So WY; Wong CS; Azubuike UF; Paul CD; Sangsari PR; Gordon PB; Gong H; Maity TK; Lim P; Yang Z; Haryanto CA; Batchelor E; Jenkins LM; Morgan NY; Tanner K
bioRxiv; 2023 Nov; ():. PubMed ID: 38076880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
